Table 2 Baseline lesion and procedural characteristics
|  | Total (n = 1420 limbs) | HbA1c < 7.0 (n = 547 limbs) | HbA1c ≥ 7.0 (n = 873 limbs) | p |
|---|---|---|---|---|
Ankle brachial index | 0.7 ± 0.3 | 0.7 ± 0.3 | 0.7 ± 0.3 | 0.777 |
TASC II classification | Â | Â | Â | 0.543 |
 A | 224 (15.8%) | 95 (17.4%) | 129 (14.8%) |  |
 B | 310 (21.8%) | 122 (22.3%) | 188 (21.5%) |  |
 C | 304 (21.4%) | 114 (20.8%) | 190 (21.8%) |  |
 D | 582 (41.0%) | 216 (39.5%) | 366 (41.9%) |  |
Number of target vessels | 1.5 ± 0.7 | 1.4 ± 0.6 | 1.5 ± 0.8 | 0.006 |
Target vessels | Â | Â | Â | 0.058 |
 Aortoiliac | 461 (32.5%) | 192 (35.1%) | 269 (30.8%) |  |
 Femoropopliteal | 666 (46.9%) | 253 (46.3%) | 413 (47.3%) |  |
 Infrapopliteal | 293 (20.6%) | 102 (18.6%) | 191 (21.9%) |  |
Total occlusion | 592 (41.7%) | 235 (43.0%) | 357 (40.9%) | 0.472 |
In-stent restenosis | 45 (3.2%) | 20 (3.7%) | 25 (2.9%) | 0.438 |
Treatment modality | Â | Â | Â | 0.918 |
 Balloon only | 582 (41.0%) | 219 (40.0%) | 363 (41.6%) |  |
 Stent | 810 (57.0%) | 321 (58.7%) | 489 (56.0%) |  |
 Others | 28 (2.0%) | 7 (1.3%) | 21 (2.4%) |  |
Lesion length (mm) | 111.7 ± 97.6 | 111.1 ± 96.1 | 112.1 ± 98.6 | 0.856 |
Diameter stenosis (%) | 88.0 ± 14.1 | 88.4 ± 14.4 | 87.9 ± 14.0 | 0.553 |